Life-Sciences-Europe.com
The European Life Sciences Web Portal

This is a free web portal for the life sciences in Europe and Israel... » read more

Creoptix AG Appoints Line Stigen Raquet as CEO (2019-12-10)
Creoptix AG, a Switzerland-based company focused on next-generation bioanalytical instruments, today announced the appointment of Line Stigen Raquet as Chief Executive Officer with effect from beginning of January 2020. After seven years in the position, Matyas Veg...
Charles River Announces Strategic Partnership with Bit Bio (2019-12-10)
Partnership will leverage Bit Bio’s unique ability to generate authentic human cells at scale Charles River Laboratories International, Inc. (NYSE: CRL) today announced that it has entered into an exclusive Discovery and Safety Services partnership with Bit Bi...
Owlstone Medical to Join EU-Funded EPHOR Consortium (2019-12-10)
Owlstone Medical will receive funding to deploy Breath Biopsy® as part of EPHOR Owlstone Medical, the global leader in Breath Biopsy® for applications in early disease detection and precision medicine, today announced it has joined the EU-funded Exposome Proje...
ImmunOs CHF15m Series A Co-led by Pfizer & BioMedPartners (2019-12-10)
ImmunOs Therapeutics AG, a Swiss biotechnology company and leading developer of a next generation innate immunity focused immunotherapy platform for cancer, announced today the closing of a Series A financing of CHF 15 million. The round was co-led by the Basel lif...
Sanofi to Acquire Synthorx for $2.35b in Cash (2019-12-09)
> Proprietary immuno-oncology (IO) platform synergistic with Sanofi’s existing therapeutic platforms > Lead asset THOR-707 (“not-alpha” IL-2) being explored across multiple solid tumor types alone and in combination with immune checkpoint inhibitors and other ...
Epidarex Exeed Founded by Epidarex Capital for Early Assets (2019-12-09)
> Epidarex’s therapeutic discovery engine will identify innovative early stage assets, providing hands-on scientific support and funding to drive drug discovery projects > Exeed will mould and de-risk opportunities, making them ready for company creation and Ser...
ObsEva: Positive Phase 3 Results for Linzagolix in HMB (2019-12-09)
> Phase 3 trial (PRIMROSE 2) met primary and secondary efficacy endpoints > 93.9% responder rate for 200 mg with ABT (p < 0.001) > 56.7% responder rate for 100 mg without ABT (p < 0.001) > Both doses achieved important clinically relevant secondary endpoin...
Algiax Raises €5.5m to Move AP-325 into Phase 2a PoC Study (2019-12-09)
Algiax Pharmaceuticals finalizes financing round and welcomes OCCIDENT and a German family office as new investors on board. Algiax Pharmaceuticals, a clinical-stage biotechnology company focused on development of GABAA receptor modulators for neuropathic pain...
Eppendorf: New CEO Dual Leadership, Bachmann Left Company (2019-12-06)
> The future initiative be Eppendorf 2021 is continued The Supervisory Board of Eppendorf AG has appointed Eva von Pelt, currently Chief Commercial Officer, and Dr. Peter Fruhstorfer, currently Head of Business Area Sample Handling, as Co-Chief Executive Off...
Life & Brain Selects Genomic Data Solutions of BC Platforms (2019-12-06)
BC Platforms, a world leader in genomic data management and analytics, today announced that it has formed a partnership with Life & Brain Genomics, a division of Life & Brain GmbH. Life & Brain Genomics is one of the leading European service providers for array-bas...

» Show all News!"

Life-Sciences-Europe.com is your doorway to the European life sciences!

[LSE] provides free, up-to-date and structured access to

– News
– Products
– Persons
– Organisations
– Financings
– Collaborations

in Europe and Israel.

Access is unrestricted and free, requiring no log in and no user registration.The high-quality content is not related to the advertising, with topical relevance being the criterion for inclusion. [LSE] is 100% Made in Germany!

Start here with the latest News!

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]